| abstract |
The present invention relates to treating obesity with or efficacy of preventing obesity of a polygonum cuspidatum butanol extract and ethyl acetate extract, and more particularly, to a pharmaceutical composition and functional food for treating obesity, which include a polygonum cuspidatum butanol extract (POCU-1b) and ethyl acetate extract as active ingredients, wherein the polygonum cuspidatum butanol extract and ethyl acetate extract have been shown to effectively inhibit pancreatic lipase activity, which is an important enzyme related to fat absorption by the body, and have shown good inhibition of fat absorption in animal experiments, using a lipid emulsion, for the short-term inhibition of fat absorption. |